Neurosurgeon Antonio Chiocca, MD, PhD, was recently appointed to the scientific advisory board of Immunomic Therapeutics.
Four things to know:
1. Dr. Chiocca has almost 25 years of experience in neuro-oncology and neurosurgery.
2. He is the Harvey W. Cushing professor of neurosurgery at Harvard Medical School in Boston as well as neurosurgeon-in-chief and chairman of the department of neurosurgery at Brigham and Women's Hospital, also in Boston.
3. Dr. Chiocca specializes in engineering biologic agents into selective anticancer agents, with a focus on brain tumors.
4. His work was featured in the Journal of Neurosurgery, Molecular Therapy as well as Neuro-oncology, and he served as president of the Society for Neuro-Oncology from 2015 to 2017.
More articles on devices:
'A dream come true': Dr. Jorge Chahla strives for success at Rush
New York hospital invests $2M in imaging system for spine, brain — 4 things to know
What Stryker's spine division stands to gain from 5 acquisitions